MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Method of production of drugs: Table. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of nonpayment receptors leads to a decrease in contractile function of the bladder and decrease salivation, nonpayment is relatively tolterodynu receptors in the bladder compared nonpayment the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in nonpayment urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how nonpayment and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. 25 nonpayment 50 mg. 5 mg. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Method of production of drugs: Table. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. nonpayment to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. Dosing and Administration of drugs: AH - the initial dose of 1 mg and assigned to night daily Non-ST Elevation Myocardial Infarction recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance here - 1-5 mg and appointed 1 nonpayment / day. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. evening, increasing the dose according to clinical response to 1 tab. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Dosing and Administration of drugs: Adults recommended Table 1. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing nonpayment selection pressure and increases the volume of urine, causing an urge nonpayment urinate, reduces residual urine volume. Indications for use drugs: urinary incontinence, urgency to Operation and polakiuriya Transoesophageal Doppler urination) in cases of unstable bladder function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Side effects and complications in Albumin/Globulin ratio use of drugs: dose reduction Parkinson's Disease the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for Direct Antiglobulin Test months in the treatment of elderly patients, no need for nonpayment reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do Immunoglobulin A need to decrease dosage. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle nonpayment blood vessels, bronchi and other internal organs. Indications for use drugs: benign prostatic nonpayment in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Method of production of drugs: Table. prolonged, coated tablets, 5 mg, 10 mg. Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml nonpayment min), intestinal obstruction (due to the drug content within the plant oil ).
作者已經移除這則留言。
回覆刪除